This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a pyrrolidine ring and a benzonitrile group, makes it valuable in the development of drugs targeting the central nervous system (CNS). It is often employed in the creation of compounds that interact with neurotransmitter receptors, particularly those involved in conditions such as Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders. Additionally, its chiral nature allows for the production of enantiomerically pure substances, which are critical for achieving specific therapeutic effects and reducing side effects in drug formulations. Researchers also explore its potential in the development of novel therapeutic agents for psychiatric and cognitive disorders due to its ability to modulate key biological pathways.